Lauren Bejzak | News | Signature Science

FOCUS: Forecasting COVID-19 in the United States

Authors: VP Nagraj, Chris Hulme-Lowe, Stephanie L. Guertin, Stephen D. Turner E-mail: sturner@signaturescience.com Abstract: Infectious disease forecasting has been a useful tool for public health planning and ...

Signature Science awarded contract to develop self-contained, single-use system for detecting synthetic opioids

System prioritizes first responder safety and ease of use.

IARPA extends support to Signature Science’s development of a laboratory-based model to predict the evolution of pandemic viruses

Second phase will build on proof-of-concept based on SARS-CoV-2 vectors

HORIZON Newsletter November 2020

Committed to Cooperation. The scientists at the Center for Advanced Genomics know that the best outcomes result from collaboration, and that’s why we, in partnership with Sam ...

Synthetic DNA and biosecurity: Nuances of predicting pathogenicity and the impetus for novel computational approaches for screening oligonucleotides

A discussion of the challenges associated with screening synthetic DNA for biosecurity risk and an argument for taking steps to move beyond the classic model of taxonomic biothreat classification and ...

New Methods, Same Motives: the IED Threat Requires a Resolute Response

THE EVOLVING THREAT The defeat of improvised explosive devices (IEDs) is, and has always been, a complex and constantly changing problem set. While the designs and methods used to build ...

News

FOCUS: Forecasting COVID-19 in the United States

Signature Science awarded contract to develop self-contained, single-use system for detecting synthetic opioids

IARPA extends support to Signature Science’s development of a laboratory-based model to predict the evolution of pandemic viruses

HORIZON Newsletter November 2020

Synthetic DNA and biosecurity: Nuances of predicting pathogenicity and the impetus for novel computational approaches for screening oligonucleotides

New Methods, Same Motives: the IED Threat Requires a Resolute Response

Categories

Recent Press

FOCUS: Forecasting COVID-19 in the United States

Signature Science awarded contract to develop self-contained, single-use system for detecting synthetic opioids

IARPA extends support to Signature Science’s development of a laboratory-based model to predict the evolution of pandemic viruses

HORIZON Newsletter February 2021

HORIZON Newsletter November 2020